Alpha Dna Investment Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Alpha Dna Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$15.46 - $24.5 $850 - $1,347	-55 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$19.33 - $37.75 $429,183 - $838,163	-22,203 Reduced 99.75%	55 $1,000
Q4 2020 Mar 24, 2021	SELL	$24.48 - $42.47 $57,772 - $100,229	-2,360 Reduced 9.59%	22,258 $549,000
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $602,648 - $1.05 Million	24,618 New	24,618 $608,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.